BCL2 and ovarian cancer: Although a relationship between paclitaxel and the intracellular Bcl-2 family has been reported [69], in which the Bcl-2 family acts in ovarian cancers that have been resensitized to paclitaxel, glutamine metabolism inhibition has not yet been elucidated.